Prognostic factors of radiographic progression in early rheumatoid arthritis: A two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids

Clinical Rheumatology

Volumn 26, Issue 7, 2007, Pages 1111-1118

  Sanmarti R ^a   Gomez Centeno A ^b   Ercilla, G ^a   Larrosa, M ^b   Vinas O ^a   Vazquez, I ^a   Gomez Puerta J A ^a   Gratacos J ^b   Salvador, G ^a   Canete J D ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL DE SABADELL   (Spain)

Author keywords

Anti CCP; Early; Prognostic; Radiographic; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; AUROTHIOMALATE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; EPITOPE; ETANERCEPT; GLUCOCORTICOID; GOLD SALT; HEMOGLOBIN; HLA DR ANTIGEN; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; ALGORITHM; ALLELE; ANTIBODY TITER; ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; FOOT RADIOGRAPHY; HAND RADIOGRAPHY; HOMOZYGOSITY; HUMAN; IMMUNOGENETICS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIVARIATE ANALYSIS; OPEN STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; TREATMENT DURATION; UNIVARIATE ANALYSIS; UNSPECIFIED SIDE EFFECT;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOCORTICOIDS; HEALTH STATUS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME;

EID: 34249904116     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0462-4     Document Type: Article

References (40)

1. Sherrer YS, Bloch DA, Mitchell DM, Young DY, Fries J (1986) The development of disability in rheumatoid arthritis. Arthritis Rheum 29:494-500
2. van der Heijde DM (2000) Radiographic imaging: The "gold standard" for assessment of disease progression in rheumatoid arthritis. Rheumatology (Oxford) 39:9-16 (Suppl)
3. Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T (1989) Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 16:585-591
4. Corbett M, Dalton S, Young A, Silman A, Shipley M (1993) Factors predicting death, survival and functional outcome in a prospective study of early rheumatoid disease over fifteen years. Ann Rheum Dis 32:717-723
5. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002) Guidelines for the management of rheumatoid arthritis. 2002 update. Arthritis Rheum 46:328-346
6. Jansen MA, van der Horst-Bruinsma IE, van Schaardenburg D, Bezemer PD, Dijkmans BA (2001) Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann Rheum Dis 60:924-927
7. Brennan P, Harrison B, Barrett E, Chakravarty K, Scott D, Silman A, Symmons D (1996) A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study. BMJ 24:471-476
8. Kroot E-J, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van't Hof M et al (2000) The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 43:1831-1835
9. Kastbom, Strandberg G, Lindroos A, Skogh T (2004) Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 63:1085-1089
10. Mattey DL, Hassell AB, Dawes PT, Cheung NT, Poulton KV,Thomson W et al (2001) Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis. Arthritis Rheum 44:1529-1533
11. Eberhardt K, Fex E, Johnson U, Wollheim FA (1996) Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis. Ann Rheum Dis 55:34-39
12. van Leeuwen MA, van Rijswijk MH, van der Heijde DM, Te Meerman GJ, van Riel PL, Houtman PM et al (1993) The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: A prospective study during the first three years of the disease. Br J Rheumatol 32:9-13 (Suppl)
13. Sanmarti R, Gómez A, Ercilla G, Gratacós J, Larrosa M, Suris X et al (2003) Radiological progression in early rheumatoid arthritis after DMARDs: A one-year follow-up study in a clinical setting. Rheumatology (Oxford) 42:1044-1049
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The America Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
15. Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP (1983) Assessment of patient satisfaction in activities of daily living using a modified Stanford health Assessment Questionnaire. Arthritis Rheum 26:1346-1353
16. Kirwan JR (2000) Using the Larsen index to assess radiographic progression in rheumatoid arthritis. J Rheumatol 27:264-268
17. Bruynesteyn K, van der Heijde D, Boers M, Lassere M, Boonen A. Edmonds J et al (2001) Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts. J Rheumatol 28: 904-910
18. Combe B, Dougados M, Goupille P, Cantagrel A, Eliaou JF, Sibilia J et al (2001) Prognostic factors for radiographic damage in early rheumatoid arthritis. A multiparameter prospective study. Arthritis Rheum 44:1736-1743
19. van Zeben D, Hazes JM, Zwinderman AH, Vanderbroucke JP, Breedveld FC (1993) Factors predicting outcome of rheumatoid arthritis: Results of a follow-up study. J Rheumatol 20:1288-1296
20. Fex E, Jonsson K, Johnson U, Eberhardt K (1996) Development of radiographic damage during the first 5-6 years of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort. Br J Rheumatol 1106-1115
21. van der Heide A, Remme CA, Hofman DM, Jacobs JW, Bijlsma JW (1995) Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum 38:1466-1474
22. Wick MC, Lindblad S, Weiss RJ, Klareskog L, van Vollenhoven RF (2004) Clinical and radiological disease-course in a Swedish DMARD-treated early RA-inception cohort: An observational study. Scand J Rheumatol 33:380-384
23. Rau R, Herborn G, Menninger H, Sangha O (2002) Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one-year double-blind study in 174 patients. Rheumatology (Oxford) 41:196-204
24. Goronzy JJ, Matteson EL, Fulbright JW, Warrington KJ, Chang-Miller A, Hunder GG et al (2004) Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum 50:43-54
25. Jones G, Halbert J, Crotty M, Shanahan EM, Batterham M, Ahern M (2003) The effect of treatment on radiological progression in rheumatoid arthritis: A systematic review of randomized placebo-controlled trials. Rheumatology (Oxford) 42:6-13
26. Wassenberg S, Rau R, Steinfeld P, Zeidler H (2005) Low-dose prednisolone therapy study group. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: A multicenter, double-blind placebo-controlled trial. Arthritis Rheum 52:3371-3380
27. Belghomari H, Saraux A, Allain J, Guedes C, Youinou P, Le Goff P (1999) Risk factors for radiographic articular destruction of hands and wrists in rheumatoid arthritis. J Rheumatol 26:2534-2538
28. Weyand CM, Hicock KC, Conn DL, Goronzy JJ (1992) The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 117:801-806
29. Hajeer AH, Dababneh A, Makki RF, Thomson W, Poulton K, Gonzalez-Gay MA (2000) Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients. Tissue Antigens 55:319-325
30. Drosos AA, Lanchbury JS, Panayi GS, Moutsopoulos HM (1992) Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiologic, and serologic study. Arthritis Rheum 35:745-748
31. Morel J, Combe B (2005) How to predict prognosis in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 19:137-146
32. Zendman AJ, Vossenaar ER, Van Venrooij WJ (2004) Autoantibodies to citrullinated (poly)peptides: A key diagnostic and prognostic marker for rheumatoid arthritis. Autoimmunity 37:295-299
33. De Rycke L, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L et al (2004) Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: Diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis 63:1587-1593
34. Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, DuboisA et al (2003) Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 62:120-126
35. Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G et al (2005) Radiological outcome in rheumatoid arthritis is predicted by the presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-rheumatoid factor at disease onset. Ann Rheum Dis 65:453-458
36. van Gaalen FA, Visser H, Huizinga TW (2005) A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis. Ann Rheum Dis 64:1510-1512
37. Scott DL (2002) The diagnosis and prognosis of early arthritis: rationale for new prognostic criteria. Arthritis Rheum 46:286-290
38. Bukhari M, Harrison B, Lunt M, Scott DG, Symmons DP, Silman AJ (2001) Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study. Arthritis Rheum 44:1248-1253
39. Bresnihan B (2002) Preventing joint damage as the best measure of biologic drug therapy. J Rheumatol 65:39-43 (Suppl)
40. van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E et al (2004) Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 50:2113-2121